This study reported a modest reduction in AKI risk with iodixanol.[ 10 ] It is debatable how clinically meaningful this risk reduction is, even though it was marginally statistically significant.
← all excerpts
The potential effect of iopamidol contrast on renal function in patients infected with SARS-CoV-2 virus: A retrospective cohort study.
1
—
—